MYH6 and hypoplastic left heart syndrome: The confirmation of these findings in a larger cohort, along with longitudinal studies of atrial function in HLHS, are warranted to identify if RA dysfunction in MYH6 variant carriers is evident throughout the lifetime of these patients and, if so, its relationship to decreased transplant-free survival.